Synapse

← Cancer Research Communications

Papers in Cancer Research Communications

Page 9 · newest first

  1. Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian CancerCancer Research Communications · 2024
  2. Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian CarcinomaCancer Research Communications · 2024
  3. Identification of ncRNA Biomarkers in Non–Small Cell Lung Cancer to Address Racial DisparitiesCancer Research Communications · 2024
  4. DeePathNet: A Transformer-Based Deep Learning Model Integrating Multiomic Data with Cancer PathwaysCancer Research Communications · 2024
  5. Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple MyelomaCancer Research Communications · 2024
  6. The Capicua C1 Domain Is Required for Full Activity of the CIC::DUX4 Fusion OncoproteinCancer Research Communications · 2024
  7. Clotting Promotes Glioma Growth and Infiltration Through Activation of Focal Adhesion KinaseCancer Research Communications · 2024
  8. Pan-Cancer Analysis of Homologous Recombination Deficiency in Cell LinesCancer Research Communications · 2024
  9. Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with AzacitidineCancer Research Communications · 2024
  10. Dynamic Evolution of Fibroblasts Revealed by Single-Cell RNA Sequencing of Human Pancreatic CancerCancer Research Communications · 2024
  11. Spatial Context of Immune Checkpoints as Predictors of Overall Survival in Patients with Resectable Colorectal Cancer Independent of Standard Tumor–Node–Metastasis StagesCancer Research Communications · 2024
  12. Elraglusib Induces Cytotoxicity via Direct Microtubule Destabilization Independently of GSK3 InhibitionCancer Research Communications · 2024
  13. The Significance of Comprehensive Metabolic Phenotypes in Cancer Risk: A Japan Multi-Institutional Collaborative Cohort StudyCancer Research Communications · 2024
  14. SpliceMutr Enables Pan-Cancer Analysis of Splicing-Derived Neoantigen Burden in TumorsCancer Research Communications · 2024
  15. Mathematical Modeling Unveils Optimization Strategies for Targeted Radionuclide Therapy of Blood CancersCancer Research Communications · 2024
  16. ETx-22, a Novel Nectin-4–Directed Antibody–Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4–Expressing TumorsCancer Research Communications · 2024
  17. PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer CellsCancer Research Communications · 2024
  18. Increased Red Cell Superoxide Dismutase Activity Is Associated with Cancer Risk: A Hidaka Cohort StudyCancer Research Communications · 2024
  19. Spatial Multiomics Reveals Intratumoral Immune Heterogeneity with Distinct Cytokine Networks in Lung Cancer Brain MetastasesCancer Research Communications · 2024
  20. Functional RNAi Screening Identifies G2/M and Kinetochore Components as Modulators of TNFα/NF-κB Prosurvival Signaling in Head and Neck Squamous Cell CarcinomaCancer Research Communications · 2024
  21. Association between Immune-Related Adverse Events and Atezolizumab in Previously Treated Patients with Unresectable Advanced or Recurrent Non–Small Cell Lung CancerCancer Research Communications · 2024
  22. Genomic Features of Newly Diagnosed Large B-cell Lymphoma with or without Subsequent Disease ProgressionCancer Research Communications · 2024
  23. Region-Based Analyses of Existing Genome-Wide Association Studies Identifies Novel Potential Genetic Susceptibility Regions for GliomaCancer Research Communications · 2024
  24. High TNF and NF-ĸB pathway dependency are associated with AZD5582 sensitivity in OSCC via CASP8-dependent apoptosisCancer Research Communications · 2024
  25. Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER- Breast CancerCancer Research Communications · 2024
  26. USP36 SUMOylates Las1L and promotes its function in pre-rRNA ITS2 processingCancer Research Communications · 2024
  27. Targeting the EGFR pathway in chemotherapy-resistant triple-negative breast cancer - a phase II studyCancer Research Communications · 2024
  28. Characterization of the Breast Cancer Liver Metastasis Microenvironment via Machine Learning Analysis of the Primary Tumor MicroenvironmentCancer Research Communications · 2024
  29. Causality between Telomere Length and the Risk of Hematologic Malignancies: A Bidirectional Mendelian Randomization StudyCancer Research Communications · 2024
  30. Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSICancer Research Communications · 2024
  31. Prostate cancer progression modeling provides insight into dynamic molecular changes associated with progressive disease statesCancer Research Communications · 2024
  32. ATF6 promotes colorectal cancer growth and stemness by regulating the Wnt pathwayCancer Research Communications · 2024
  33. GALAD score for the diagnosis of Hepatocellular Carcinoma in sub-Saharan Africa; a validation study in Ghanaian patients.Cancer Research Communications · 2024
  34. DNA Methylation-Derived Immune Cell Proportions and Cancer Risk in Black ParticipantsCancer Research Communications · 2024
  35. A precision engineered interleukin-2 (IL-2) for bolstering CD8+ T- and NK-cell activity without eosinophilia and vascular leak syndrome in non-human primatesCancer Research Communications · 2024
  36. Intraoperative guidance of pancreatic cancer resection using a toll like receptor 2 targeted fluorescence molecular imaging agentCancer Research Communications · 2024
  37. Peripheral blood interferon responses to toll-like receptor 1/2 signaling associate with longer survival in men with metastatic prostate cancer treated with Sipleucel-T.Cancer Research Communications · 2024
  38. Blocking tryptophan catabolism reduces triple-negative breast cancer invasive capacityCancer Research Communications · 2024
  39. Oncogenic Mutant p53 Sensitizes Non-Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress-Dependent Induction of Mitochondrial ApoptosisCancer Research Communications · 2024
  40. Small molecule CCR4 antagonists in cutaneous T-cell lymphomaCancer Research Communications · 2024
  41. Peroxisome proliferator-activated receptor δ suppresses the cytotoxicity of CD8+ T cells by inhibiting RelA DNA binding activityCancer Research Communications · 2024
  42. Preclinical Evaluation of STI-8811, a Novel Antibody Drug Conjugate Targeting BCMA for the Treatment of Multiple MyelomaCancer Research Communications · 2024
  43. Chemotherapy enriches for pro-inflammatory macrophage phenotypes that support cancer stem-like cells and disease progression in ovarian cancerCancer Research Communications · 2024
  44. Hypophosphatemia correction reduces ICANS incidence and duration in CAR T-cell therapy: a pooled clinical trial analysisCancer Research Communications · 2024
  45. PELP1 is a novel therapeutic target in hepatocellular carcinomaCancer Research Communications · 2024
  46. Antiangiogenic tyrosine kinase inhibitors have differential efficacy in clear cell renal cell carcinoma in boneCancer Research Communications · 2024
  47. Combined Oxygen-enhanced MRI and perfusion imaging detect hypoxia modification from banoxantrone and atovaquone and track their differential mechanisms of actionCancer Research Communications · 2024
  48. Autofluorescent Cancer Stem Cells: Potential Biomarker to Predict Recurrence in Resected Colorectal TumorCancer Research Communications · 2024
  49. Therapeutic efficacy of IL-7/CCL19-expressing CAR-T cells in intractable solid tumor models of glioblastoma and pancreatic cancerCancer Research Communications · 2024
  50. NCI's Proteomic Data Commons: A Cloud-Based Proteomics Repository Empowering Comprehensive Cancer Analysis Through Cross-Referencing with Genomic and Imaging DataCancer Research Communications · 2024